News / Blog
Celebrating a Partnership for Progress in Osteosarcoma | St. Baldrick's Blog
Osteosarcoma Collaborative Impact Statement
First We opened a Phase 1 clinical trial for
pulmonary metastatic osteosarcoma based
on a new understanding of factors that are
critical for tumor cells to survive.
Next Discovered that a sugar on the outer shell ofthe oat
bran can stop tumor growth, leading to Orphan
Drug Designationand Rare Disease Designation by
the FDA for use as anosteosarcoma treatment.
Then Provided data supporting the use of anexisting
drug being tested in adult cancers for pediatric
osteosarcona treatment, leading to Orphan Drug
Designation by the FDA for use as anosteosarcoma
treatment.
Now Currently developing two future clinical
trials for advanced osteosarcoma treatment.
St. Baldrick's Foundation, The Osteosarcoma Collaborative and others are currently fundraising to support a second call for research applications, aiming to make even more of an impact for children with osteosarcoma.
News/Blog
Request For Applications for Osteosarcoma Research Grant
Announcing a Request For Applications (RFA) for high-impact pediatric osteosarcoma translational research with a focus on moving quickly toward improvements in outcomes for patients. This RFA is to be administered by the St. Baldrick’s Foundation, supported by the...
Oliver Feldman
Make A DonationOliver Feldman was 16 when his right arm began hurting him. At first, he thought it was due to a skiing trip with the scouts, nothing seemed to be broken and going to the chiropractor brought some relief. He had also been given the ok from the NP for...
David Robbins
David Robbins3/22/1999 - 11/30/2017 David Robbins passed away peacefully at his Rockville home on November 30, 2017. He is survived by his loving mother Christiane; his devoted sister Gabrielle ; as well as the love of his life Alicia O’Neil, his best friend Alex Le,...
Austin Cohen
Make a DonationIn early 2014, the shocking news came that Austin had cancer. It was shocking that a young healthy athlete had cancer. The family was told, “thankfully there is a 30-year proven treatment plan and we no longer need to rely on amputation”. When the...
Count Me In
Funding from the National Cancer Institute will help optimize patient engagement in research while studying osteosarcoma and leiomyosarcoma The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Count Me In, a non-profit research initiative that...
Tumor Testing
In many adult cancers, at diagnosis, a biopsy of the tumor is done and some of the tumor tissue is sent off for genetic testing. Then, depending on the results of the genetic testing, a particular treatment is chosen by the doctor. For Osteosarcoma there is only one...
Germline Testing
When a child is diagnosed with osteosarcoma very young (typically below the age of 10) or has a strong family history of sarcomas/breast cancer/GBM, or when a patient relapses, genetic testing may be mentioned. There are two distinct types of genetic testing looking...